Lutein is a yellow carotenoid your body cannot make. You get it from leafy greens, sweetcorn and egg yolk, and it concentrates in the macula at the centre of the retina, where it filters blue light. Randomised trials show it sharpens contrast in healthy eyes and slows late age-related macular degeneration over ten years.
Search for lutein in the UK and the first thing you meet is a number: 43 per cent lower risk of macular degeneration. It appears in the page title of the first result. It comes from an observational study, not a trial, and the randomised evidence tells a quieter story.
This article separates the two: what the cohorts suggested, what happened when researchers randomised people, and what a supplement label is legally allowed to say in Great Britain. Every figure below traces to a study listed at the end.
What is lutein, and why does it end up in your eye?
Lutein is a xanthophyll, one branch of the carotenoid family that colours plants yellow, orange and red. Plants make it. Animals, including you, do not. Every milligram in your body arrived through food.
What makes it unusual is where it goes. Most carotenoids scatter through fat tissue and the liver. Lutein and its relatives zeaxanthin and meso-zeaxanthin travel to one small spot: the macula, the few square millimetres of retina responsible for reading, faces and fine detail. There they form a yellow screen called the macular pigment.
That screen does two jobs. It absorbs short-wavelength blue light before it reaches the photoreceptors, which cuts the glare that blurs edges. And it mops up the reactive oxygen produced by an organ that spends its life pointed at light, the same chemistry behind any approach to the inflammatory load carried by ageing tissue.
FROM THE PLATE TO THE MACULA
Does lutein really help your eyes?
Yes, but the size of the benefit depends on which question you ask, and the popular answer merges two different bodies of evidence.
What eating more lutein looks like in population data
Ma and colleagues pooled six long-running cohort studies and compared people with the highest dietary lutein and zeaxanthin intake against those with the lowest. For early macular degeneration, nothing: a relative risk of 0.96, with a confidence interval that sits comfortably across 1. For late disease, a 26 per cent lower risk. For the neovascular form, the wet type that destroys central vision fastest, 32 per cent lower.
That is a real signal, and the origin of the headline numbers. It is also the weakest form of evidence, because people who eat a lot of kale differ from people who eat none in a hundred other ways.
What happened when researchers randomised it
AREDS2 was built to test exactly that. The American National Eye Institute recruited 4 203 people aged 50 to 85 who already had large drusen, the deposits that mark an eye at risk, and randomly assigned them 10 mg of lutein with 2 mg of zeaxanthin, or omega-3, or both, or placebo.
After a median of five years, 31 per cent of placebo eyes had progressed to advanced disease. In the lutein and zeaxanthin group, 29 per cent had. The primary analysis found no statistically significant reduction. The trial meant to confirm the cohort finding did not.
THE HEADLINE AND THE TRIAL, ON THE SAME QUESTION
WHAT THE SEARCH RESULTS SAY
- “6 mg per day led to a 43% lower risk of macular degeneration.”
- The figure comes from comparing people who already ate differently.
- It is quoted without the study design attached to it.
WHAT AREDS2 MEASURED
- 4 203 people randomised, median follow-up 5 years.
- 31% of placebo eyes progressed, against 29% on lutein and zeaxanthin.
- No statistically significant reduction in the primary analysis.
Why the ten-year follow-up changed the answer
Here is the part almost nobody quotes. Participants were followed another five years. Across 3 882 people, progression to late macular degeneration was lower with lutein and zeaxanthin than without: a hazard ratio of 0.91, and this time the confidence interval cleared 1.
The comparison that matters most for anyone buying a supplement is the direct one. Against beta-carotene, the carotenoid the old formula used, lutein and zeaxanthin cut progression to late disease by 15 per cent. And beta-carotene almost doubled the ten-year odds of lung cancer in that cohort, an effect lutein did not show. That is the pattern the large antioxidant supplement trials produced more generally, where isolated high-dose antioxidants raised all-cause mortality slightly rather than lowering it. Lutein did not beat placebo dramatically. It clearly beat the thing it replaced.
AREDS2: PROGRESSION TO LATE MACULAR DEGENERATION
What lutein does for eyes that are still healthy
Macular degeneration is not the reason most people under 60 take lutein. The question there is whether it does anything for ordinary vision.
The Central Retinal Enrichment Supplementation Trial, run in Waterford, answered that properly. Researchers took 105 people free of retinal disease but with naturally low macular pigment, and gave 53 of them 10 mg lutein, 2 mg zeaxanthin and 10 mg meso-zeaxanthin daily for twelve months. The rest got placebo.
Contrast sensitivity improved significantly against placebo, and the size of each person’s improvement tracked how much pigment they had actually built up. That is the detail that makes the result hard to dismiss. The eyes that absorbed more saw better.
Contrast sensitivity is not the letters on the optician’s chart. It is separating a grey kerb from a grey pavement at dusk. A normal 6/6 acuity reading tells you nothing about it.
Which foods are highest in lutein?
Dark leafy greens dominate, and cooked beats raw because heat collapses the leaf and concentrates what is left. Kale and spinach sit an order of magnitude above everything else.
| Food | Approximate lutein and zeaxanthin | Practical note |
|---|---|---|
| Cooked kale, 100 g | 15 to 18 mg | The single richest common source in a British diet |
| Cooked spinach, 100 g | 11 to 12 mg | Frozen works as well as fresh |
| Cooked broccoli, 100 g | 1 to 2 mg | Useful, not comparable to greens |
| Sweetcorn, 100 g | 0.6 to 0.9 mg | Low in weight terms, high in portion terms |
| Egg yolk, 2 yolks | 0.3 to 0.4 mg | Small dose, best absorbed, the fat comes built in |
| Avocado, half a fruit | 0.2 to 0.3 mg | Same absorption advantage as egg |
The absorption column matters more than the milligrams. Two egg yolks carry a fortieth of the lutein in a plate of kale, yet they raise blood levels efficiently, because the carotenoid arrives dissolved in fat. Greens need help. Olive oil on the spinach is the delivery mechanism, not a garnish, and the same is true of every fat-soluble pigment on the plate.
A realistic British diet delivers somewhere between 1 and 3 mg a day. Every trial described above used 10 mg or more. That gap is the honest argument for supplementing, and it is a much better one than any percentage in a headline.
What a lutein supplement can legally claim in the UK
Read the two lutein products that rank on the first page of Google in Britain and you will notice something. Both are sold at 50 mg. Neither claims that lutein does anything. One says it contains “vitamin B2 to support the maintenance of normal vision”.
That is not marketing coyness, it is the law. Health claims on supplements sold in Great Britain must appear on the GB Nutrition and Health Claims Register, and lutein is not on it. Riboflavin is, with authorised wording about maintaining normal vision. So the vision claim on a lutein bottle usually belongs to a vitamin added alongside it.
The gap is not an oversight. When a manufacturer applied for a claim on a fixed combination of lutein, zeaxanthin and DHA in egg yolk, the European panel found that the only usable study showed no effect on vision, and refused it. Evidence good enough to publish is not automatically evidence good enough to print on a label.
So ignore the front of the box and read the back. What matters is the milligrams of lutein per capsule, and whether that lutein is free or esterified.
FloraGLO, esters and why the form on the label matters
Lutein is extracted from marigold petals, almost always Tagetes erecta, grown commercially in India. The petals are pressed into an oleoresin, and at that point the lutein is bound to fatty acids as a diester. Your gut has to cleave those bonds before anything is absorbed.
Two things can then happen. The ester can be sold as it is, which is cheaper and carries a heavier milligram figure because the fatty acid tails count towards the weight. Or it can be saponified into free lutein, which is what the retina receives and what the trials used. AREDS2 ran on the branded free-form ingredient FloraGLO, standardised at a 10:2 ratio with zeaxanthin. Form deciding absorption is not peculiar to carotenoids: quercetin behaves the same way, where the sugar attached to it in an onion changes how much reaches the blood and the free form sold in capsules is the least soluble of all.
In the United States that brand name is a shelf signal. In Britain it is almost absent, and no UK shopper needs to hunt for it. What transfers is the specification underneath: free lutein rather than ester, a stated figure for the lutein itself, and zeaxanthin at roughly 10 to 2.
FREE LUTEIN
The saponified molecule. What AREDS2 and CREST used, and what the label figure refers to directly.
LUTEIN ESTERS
Bound to fatty acids. Cheaper, and the stated weight includes the tails, so 20 mg of ester is not 20 mg of lutein.
MARIGOLD EXTRACT
The raw oleoresin from Tagetes erecta petals, before any standardisation. A percentage, not a dose.
How much lutein, and is it safe to take every day?
Trial doses cluster tightly. AREDS2 used 10 mg of lutein with 2 mg of zeaxanthin, CREST the same pair plus 10 mg of meso-zeaxanthin, the cognition trial 10 mg and 2 mg again. Nothing in the randomised literature supports the 50 mg tablets that dominate the British market, and nothing suggests they do harm.
Long-term daily use has a good safety record. Across five years of AREDS2 the lutein groups reported no excess of serious adverse events, the reassurance the older beta-carotene formula could not offer. The one visible effect of very high carotenoid intake is carotenodermia, a yellow-orange tint to the palms that reverses when you stop.
Two situations deserve a conversation with your GP or pharmacist first. If you smoke or used to, check what else is in the tablet: it is beta-carotene, not lutein, that carries the lung cancer signal, and combined eye formulas still sometimes contain it. And if you take a fat absorption blocker such as orlistat, or a bile acid sequestrant, absorption of every fat-soluble nutrient drops, lutein included.
No recommended daily intake has been set for lutein, because it is not classed as a vitamin. If you already have diagnosed macular degeneration, your ophthalmologist decides what formula fits, not a supplement website.
Lutein beyond the eye: brain and skin
Lutein does not stop at the retina. It crosses into brain tissue, closely enough that researchers use the macula as a window on the head.
Renzi-Hammond and colleagues tested whether that mattered in people nowhere near old age. Fifty-one healthy adults aged 18 to 30 took 10 mg of lutein with 2 mg of zeaxanthin, or placebo, for a year. Macular pigment rose in the supplemented group, and so did spatial memory, reasoning and complex attention, beyond what practice on the tests explained.
Fifty-one people is a small trial, and one result is not a body of evidence. Treat it as a reason to watch the field rather than a reason to buy.
What recurs across all of this is dietary rather than pharmaceutical. The people with high macular pigment are the people eating coloured plants every day, the same pattern that shows up when researchers look at joint comfort and stiffness in older adults. Lutein is one measurable marker of a way of eating, not a substitute for it.
Frequently asked questions
Does lutein really help for eyes?
For contrast sensitivity in healthy eyes, yes: the CREST trial improved it against placebo over 12 months. For macular degeneration, the ten-year AREDS2 follow-up found a lower rate of progression to late disease with lutein and zeaxanthin, hazard ratio 0.91. The five-year primary analysis had not reached significance.
Which food is highest in lutein?
Cooked kale, at roughly 15 to 18 mg per 100 g, followed by cooked spinach at 11 to 12 mg. Everything else is an order of magnitude behind. Egg yolk carries far less but is absorbed best, because the lutein arrives already dissolved in fat.
Is it okay to take lutein every day?
Daily use at 10 to 20 mg was well tolerated across five years of AREDS2 and twelve months of CREST. Lutein is fat-soluble, so take it with a meal containing some fat. There is no set recommended intake in the UK, because lutein is not classed as a vitamin.
Who should not take lutein?
Anyone who smokes or has smoked should check the full ingredient list rather than the lutein itself: beta-carotene in combined eye formulas carries a lung cancer signal that lutein does not. Speak to your GP first if you are pregnant, breastfeeding, or already treated for macular degeneration.
What are the side effects of taking lutein?
Reported effects are uncommon and mild, mainly stomach discomfort. Very high carotenoid intake can produce carotenodermia, a harmless yellow-orange tint to the palms and soles that fades once intake drops. No serious adverse effect was linked to lutein in AREDS2.
What not to mix with lutein?
Anything that blocks fat absorption will cut how much you take up, including orlistat and bile acid sequestrants. Very high doses of beta-carotene compete with lutein for the same absorption pathway. Separating them by a few hours, or choosing a formula without beta-carotene, avoids the issue.
Does lutein help eye floaters?
No trial has tested that. Floaters come from collagen strands in the vitreous gel casting shadows, a mechanical change lutein has no route to reach. Sudden new floaters, especially with flashes or a shadow across your vision, need same-day assessment at an eye casualty department.
Sources
- Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA, 2013. DOI: 10.1001/jama.2013.4997
- Chew E.Y., Clemons T.E., Agron E., et al. Long-term outcomes of adding lutein/zeaxanthin and omega-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28. JAMA Ophthalmology, 2022. DOI: 10.1001/jamaophthalmol.2022.1640
- Ma L., Dou H.L., Wu Y.Q., et al. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. British Journal of Nutrition, 2011. DOI: 10.1017/S0007114511004260
- Nolan J.M., Power R., Stringham J., et al. Enrichment of macular pigment enhances contrast sensitivity in subjects free of retinal disease: Central Retinal Enrichment Supplementation Trials, report 1. Investigative Ophthalmology and Visual Science, 2016. DOI: 10.1167/iovs.16-19520
- Renzi-Hammond L.M., Bovier E.R., Fletcher L.M., et al. Effects of a lutein and zeaxanthin intervention on cognitive function: a randomized, double-masked, placebo-controlled trial of younger healthy adults. Nutrients, 2017. DOI: 10.3390/nu9111246
- Li L.H., Lee J.C., Leung H.H., et al. Lutein supplementation for eye diseases. Nutrients, 2020. DOI: 10.3390/nu12061721
- EFSA Panel on Dietetic Products, Nutrition and Allergies. NWT-02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk and reduction of the loss of vision. EFSA Journal, 2018. DOI: 10.2903/j.efsa.2018.5139
This article is general information, not medical advice. Speak to your GP, pharmacist or optometrist before starting a supplement, particularly if you take medication, are pregnant, or are already under the care of an eye clinic.
